Ptc Therapeutics Inc (PTCT)
$59.97 -6.97% Close Oct 30, 2026 Live
Ptc Therapeutics stock today
Ptc Therapeutics closed at $59.97 on October 30, 2026, down 6.97% on the day. Over the past year it returned -12.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $5.00 billion.
$60.00$70.00$80.00$90.00
NovJan 2026MarMayJulSep
| Period | PTCT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -7.4% | -0.9% |
| 3 months | -20.6% | +2.1% |
| Year to date | -21.1% | +11.7% |
| 1 year | -12.0% | +12.4% |
| 3 years | +220.0% | +88.5% |
| 5 years | +58.1% | +76.0% |
Key statistics
- Market value
- $5.00B
- Forward P/E
- 27.8
- Price / sales
- 4.3
- 52-week range
- $59.24 to $89.55
About Ptc Therapeutics
Develops therapies for genetic disorders and cancers using RNA-modulating technology.
Sector: Health Care
More on Ptc Therapeutics
- Financials: revenue, earnings and segmentsRevenue +115% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $9,385 today
No forecast, no recommendation. This page describes Ptc Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.